PF-04449913 For Patients With Acute Myeloid Leukemia at High Risk of Relapse After Donor Stem Cell Transplant

NCT01841333 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Adult Acute Myeloid Leukemia in Remission
Recurrent Adult Acute Myeloid Leukemia

Interventions

DRUG: PF-04449913

Sponsor

University of Colorado, Denver

Collaborators

[object Object]